KORR; Daniel

Patent Applications and Registrations

Patent applications and USPTO patent grants for KORR; Daniel.The latest application filed is for "4h-pyrrolo[3,2-c]pyridin-4-one compounds".

Company Profile

1.5.14

KORR; Daniel - Berlin DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
4h-pyrrolo[3,2-c]pyridin-4-one Compounds App 20220298157 - SIEGEL; Stephan ; et al.	2022-09-22
Acyl Sulfonamides For Treating Cancer App 20220226279 - Bouche; Lea Aurelie ; et al.	2022-07-21
4H-pyrrolo[3,2-c]pyridin-4-one derivatives Grant 11,339,157 - Siegel , et al. May 24, 2	2022-05-24
Thiazole Compounds Useful As Prmt5 Inhibitors App 20200123147 - BOUCHE; Lea Aurelie ; et al.	2020-04-23
Substituted aminoimidazopyridazines Grant 9,730,929 - Eis , et al. August 15, 2	2017-08-15
Heterocyclyl aminoimidazopyridazines Grant 9,284,319 - Eis , et al. March 15, 2	2016-03-15
Heterocyclyl Aminoimidazopyridazines App 20150038485 - Eis; Knut ; et al.	2015-02-05
Amino-substituted Imidazopyridazines As Mknk1 Kinase Inhibitors App 20140288069 - Eis; Knut ; et al.	2014-09-25
Substituted Aminoimidazopyridazines App 20140194430 - Eis; Knut ; et al.	2014-07-10
Progesterone-receptor Antagonist For Use In Brca Alone Or As Combination With Antiestrogen App 20090029954 - HOFFMANN; Jens ; et al.	2009-01-29
USE OF FIBROBLAST GROWTH FACTOR 7 (Fgf7) AND OF THE RECEPTOR Fgfr2b AS BIOMARKERS App 20080311594 - Hoffman; Jens ; et al.	2008-12-18
Combination Of Progesterone-receptor Antagonist Together With None-steroidal Antiestrogen For Use In Brca Mediated Diseases App 20080268041 - Hoffmann; Jens ; et al.	2008-10-30
Combination Of Progesterone-receptor Antagonist Together With A Lutein-hormone-releasing Hormone Agonist And Antagonist For Use In Brca Mediated Diseases App 20080261933 - Hoffmann; Jens ; et al.	2008-10-23
Combination Of Progesterone-receptor Antagonist Together With An Aromatase Inhibitor For Use In Brca Mediated Diseases App 20080261929 - Hoffmann; Jens ; et al.	2008-10-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.